Evidence map›Paper›PMID 32588543›Full record

ArticleJournal of cellular and molecular medicine2020

Antibacterial potential of Forsythia suspensa polysaccharide against resistant Enterobacter cloacae with SHV-12 extended-spectrum β-lactamase (ESBL).

Jun Liu, Liyao Lin, Zhen Jia, Jing Chen, Zuguo Zhao, Yi Zhao, Zhujin Xu, Zhen Guo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Characterization of Silver Nanoparticles Synthesized by Leaves ofInternational journal of nanomedicine · 2022
    Article
  4. Article
  5. Journal of evidence-based integrative medicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jun LiuLaboratory of Pathogenic Biology, Guangdong Medical University, Zhanjiang, China.ORCID 0000-0003-2746-9303
Liyao LinDepartment of Cardiothoracic Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Zhen JiaDepartment of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Jing ChenGeriatrics Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Zuguo ZhaoLaboratory of Pathogenic Biology, Guangdong Medical University, Zhanjiang, China.
Yi ZhaoLaboratory of Pathogenic Biology, Guangdong Medical University, Zhanjiang, China.
Zhujin XuLaboratory of Pathogenic Biology, Guangdong Medical University, Zhanjiang, China.
Zhen GuoLaboratory of Pathogenic Biology, Guangdong Medical University, Zhanjiang, China.
Guangdong Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, a homogenous polysaccharide (FSP), with an average molecular weight of 9.08 × 10

Indexed as

beta-Lactam ResistanceAnti-Bacterial Agentsbeta-LactamasesBiofilmsChemical FractionationEnterobacter cloacaeForsythiaGene Expression Regulation, BacterialMicrobial Sensitivity TestsPlant ExtractsPolysaccharidesAnti-Bacterial Agentsbeta-Lactamasesbeta-lactamase SHV-12Plant ExtractsPolysaccharidesantibacterial activityEnterobacter cloacae producing SHV-12 ESBLForsythia suspense polysaccharide

Identifiers

PMID32588543
PMCPMC7412404
OpenAlexW3037885439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.